![]() Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs. | ![]() Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. | ![]() Promethera Biosciences Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases. | |
Founding Date | Founding Date 1999 | Founding Date 2001 | Founding Date 2009 |
Type | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||
Locations | Locations Loos, FR HQ Cambridge, US | Locations Gent, BE HQ | Locations Mont-Saint-Guibert, BE HQ Charleroi, BE Ganshoren, BE Chuo City, JP Chuo City, JP Basel, CH Durham, US see more |
Employees | Employees 180 | Employees 1252% decrease | Employees 185% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) €65.4m (FY, 2025) | Revenue (est.) €85.2m (FY, 2016) | Revenue (est.) N/A |
Net income | Net income (€86m) (FY, 2025) | Net income (€1.1m) (FY, 2016) | Net income N/A |
Operating ⚠ | |||
Patents (Foreign) | Patents (Foreign) 450 (FY, 2019) | Patents (Foreign) 180 (Q2, 2017) | Patents (Foreign) N/A |
Patents (US) | Patents (US) 28 (FY, 2019) | Patents (US) 50 (Q2, 2017) | Patents (US) N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 498.8m | Total funding raised $ 146m |

Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
View company
Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases.
View company